参考文献/References:
[1] 中华医学会皮肤性病学分会药物不良反应研究中心. Stevens-Johnson综合征/中毒性表皮坏死松解症诊疗专家共识[J].中华皮肤科杂志,2021,54(5):376-381.
[2] Lerch M,Mainetti C,Terziroli B,et al.Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Clin Rev Allergy Immunol,2018,54(1): 147-176.
[3] Yacoub M R, Berti A, Campochiaro C, et al. Drug induced exfoliative dermatitis: state of the art[J]. Clin Mol Allergy,2016, 14(1): 9.
[4] 刘瑞,张志彬,杨科,等. Stevens-Johnson综合征和中毒性表皮坏死松症病死率及相关因素的Meta分析[J]. 中国皮肤性病学杂志,2024,38(1):65-73.
[5] 刘雪姣,岳慧杰,吴燕子,等.多药联用致中毒性表皮坏死松解症1例分析[J]. 中国药物警戒,2022(2):219-220-227.
[6] 李悦,聂振华,孔祥君,等.中毒性表皮坏死松解症2例并文献复习[J]. 中国中西医结合皮肤性病学杂志,2023,22(1):72-74.
[7] 曾荣,刘海燕.复方氨林巴比妥柴胡混合肌注致药物性皮疹1例[J].药物流行病学杂志,2007,16(4):248.
[8] 罗兴献,刘一,薛学财,等.非甾体抗炎药致重症药疹文献汇总分析[J].中国医院药学杂志,2017,37(21):2155-2159.
[9] Hsu D Y, Brieva J, Silverberg N B, et al. Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults[J]. J Invest Dermatol, 2016,136(7):1387-1397.
[10] Bastuji-Garin S, Fouchard N, Bertocchi M, et al. Scorten: a severity-of-illness score for toxic epidermal necrolysis[J]. J Invest Dermatol, 2000,115(2):149-153.
[11] 高澜,劳力民.中毒性表皮坏死松解症病因及发病危险因素研究进展[J]. 中国麻风皮肤病杂志,2023,39(5):382-386.
[12] 王倩,漆波,张丽霞,等. SCORTEN和ABCD-10评估Stevens-Johnson综合征/中毒性表皮坏死松解症预后的比较[J].中华皮肤科杂志,2022,55(7):566-570.
[13] 祝可元,蒋法兴,常瑞雪,等. 15 例中毒性表皮坏死松解症回顾性分析[J].皮肤病与性病,2021,43(1):88-90.